6618 — JD Health International Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$77.97bn
- HK$34.37bn
- CNY53.53bn
- 91
- 36
- 10
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | PROSPECTUS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | -972 | -17,235 | -1,073 | 383 | — |
Depreciation | |||||
Non-Cash Items | 1,459 | 18,051 | 2,241 | 2,168 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -648 | 2,856 | 2,199 | 3,213 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -152 | 3,699 | 3,431 | 5,905 | — |
Capital Expenditures | -5.69 | -38.8 | -518 | -2,273 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -1,443 | -7,804 | -17,234 | -1,963 | — |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,449 | -7,843 | -17,752 | -4,236 | — |
Financing Cash Flow Items | 200 | -219 | -75 | -8.85 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 6,509 | 32,029 | -164 | -925 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 4,949 | 27,306 | -15,018 | 1,465 | — |